NEWS

May 8, 2024

Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029

April 10, 2024

Zevra Therapeutics Refinances Existing Debt With Up To $100M In Committed Capital Under New Credit Facility

March 4, 2024

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million

January 4, 2024

Liquidia Corporation Announces $100 Million in New Financings

January 3, 2024

HealthCare Royalty Announces Closing of Additional Debt Focused Fund, Team Expansion, and Promotions

November 2, 2023

Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty

October 24, 2023

HealthCare Royalty Announces Closing of Credit Facility, New Debt Focused Fund and Appointment of Josh House as West Coast Lead

August 22, 2023

TheracosBio Announces Royalty Financing Agreement with HealthCare Royalty

August 3, 2023

Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty

May 15, 2023

uniQure Announces Sale of Royalty Interest in HEMGENIX ^® for Up To $400 Million